Is IL-2 regulated by a serum inhibitor?

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Cellular Immunology

• Publication date

  1985-10-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0008-8749(85)90318-1PMID 3876161
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antigenic stimulation regulates the expression of IL 2 receptors in a cytolytic T lymphocyte clone.

  1985cited by this paper
• Antigen-independent activation of memory cytotoxic T cells by interleukin 2.

  1984cited by this paper
• Inhibition of interleukin-2-induced proliferation of mouse T cells by normal mouse serum.

  1983cited by this paper
• In vivo development of cytolytic T lymphocytes (CTL) to hapten-altered self: MIs-disparate cells facilitate the response by neutralizing IL 2 inhibitor.

  1983cited by this paper
• Activation of cytotoxic T lymphocytes requires at least two spleen cell-derived helper factors besides interleukin 2.

  1983cited by this paper
• In vivo interleukin 2 administration augments the generation of alloreactive cytolytic T lymphocytes and resident natural killer cells.

  1983cited by this paper
• The fate of interleukin-2 after in vivo administration.

  1983cited by this paper
• Purification of mouse interleukin 2 to apparent homogeneity.

  1983cited by this paper
• Generation of alloreactive cytotoxic T lymphocytes: evidence for a differentiation factor distinct from IL 2.

  1983cited by this paper
• Expansion of cyclophosphamide-resistant cytotoxic precursors in vitro and in vivo by purified human interleukin 2.

  1983cited by this paper
• Dissection of the proliferative and differentiative signals controlling murine cytotoxic T lymphocyte responses

  1982cited by this paper
• Cellular and molecular properties of an antigen-specific cytotoxic T lymphocyte line.

  1982cited by this paper
• Clearance of interleukin 2 from the blood of normal and T cell‐depleted mice

  1982cited by this paper
• Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin 2

  1982cited by this paper
• Interleukin-2 augments natural killer cell activity

  1981cited by this paper
• Translation of lymphocyte mRNA into biologically-active Interleukin 2 in oocytes.

  1981cited by this paper
• Biologic properties of chromatographically separated murine thymoma-derived Interleukin 2 and colony-stimulating factor.

  1981cited by this paper
• Lyt-23+ cyclophosphamide-sensitive T cells regulate the activity of an interleukin 2 inhibitor in vivo

  1981cited by this paper
• Immunosuppressive effect of mouse serum lipoproteins. I. In vitro studies.

  1981cited by this paper
• Cellular Origins and Targets of Costimulator (IL2)

  1980cited by this paper
• Cellular origins of co-stimulator (IL2) and its activity in cytotoxic T lymphocyte responses.

  1980cited by this paper
• Thymoma production of T cell growth factor (Interleukin 2).

  1980cited by this paper
• Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves.

  1978cited by this paper
• T cell growth factor: parameters of production and a quantitative microassay for activity.

  1978cited by this paper
• Enzyme changes in neonatal skeletal muscle: effect of thyroid deficiency.

  1978cited by this paper
• Statistical characterization of the random errors in the radioimmunoassay dose--response variable.

  1976cited by this paper
• Biological expressions of lymphocyte activation. V. Characterization of a soluble immune response suppressor (SIRS) produced by concanavalin A-activated spleen cells.

  1976cited by this paper
• Selective in vitro growth of T lymphocytes from normal human bone marrows.

  1976cited by this paper
• Effect of normal mouse serum on mouse lymphocyte transformation in vitro

  1974cited by this paper
• Characterization of an immunosuppressive factor present in mouse serum.

  1973cited by this paper
• Transformation of Human Lymphocytes: Inhibition by Homologous Alpha Globulin

  1968cited by this paper

• Normal mouse serum‐derived factor(s) which inhibits growth of the interleukin‐2‐dependent cell line CTLL

  1992cites this paper
• Serum immunomodulatory factors in gastrointestinal diseases. A 30‐50‐kD serum fraction in Crohn's disease capable of modulating lymphocyte activation

  1991cites this paper
• Multiple inhibitors of mitogen-induced proliferation of normal lymphocytes in juvenile chronic arthritis sera.

  1990cites this paper
• Characterization of a specific inhibitor of IL2-mediated proliferation from serum of Plasmodium berghei infected mice.

  1988cites this paper
• Interleukin 2inhibitor insynovial fluid

  1988cites this paper
• Con A-stimulated thymocytes produce interleukin 2 after removal of Lyt-1 positive cells.

  1988cites this paper
• Interleukin 2 inhibitor in synovial fluid.

  1988cites this paper
• Is there an interleukin 2 inhibitor in human serum?

  1987cites this paper
• Bioassay for interleukin-2 inhibitors.

  1987cites this paper
• Apparent interleukin 2 (IL-2) inhibitory activity of human serum is due to rapid killing of IL-2-dependent mouse cells.

  1987cites this paper
• A Soluble 61-kDa Protein is Associated with Inhibition of Lectin-Induced Proliferation and IL-2 Synthesis 1

  1987cites this paper
• Generation and measurement of interleukin‐1, interleukin‐2, and mitogen levels in small volumes of whole blood

  1987cites this paper
• Bioassay for interleukin-2 inhibitors

  1987cites this paper
• Interactions of viruses with the immune system.

  1986cites this paper